Celldex Therapeutics Announces Upcoming Presentation at Leerink Swann Global
Healthcare Conference 2013
NEEDHAM, Mass., Feb. 11, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc.
(Nasdaq:CLDX) announced today that Anthony Marucci, President and Chief
Executive Officer, is scheduled to present a corporate overview at the Leerink
Swann Global Healthcare Conference 2013 on Wednesday, February 13, 2013 at
11:30 am ET at The Waldorf Astoria New York.
A live webcast of the presentation will be available online on the "Events &
Presentations" page of the "Investors & Media" section of the Celldex website.
A replay of the presentation will be available for 90 days following the
About Celldex Therapeutics, Inc.
Celldex Therapeutics is the first antibody-based combination immunotherapy
company. Celldex has a pipeline of drug candidates in development for the
treatment of cancer and other difficult-to-treat diseases based on its
antibody focused Precision Targeted Immunotherapy (PTI) Platform. The PTI
Platform is a complementary portfolio of monoclonal antibodies,
antibody-targeted vaccines and immunomodulators used in optimal combinations
to create novel disease-specific drug candidates.
CONTACT: Sarah Cavanaugh
Vice President of IR & Corp Communications
Celldex Therapeutics, Inc.
Press spacebar to pause and continue. Press esc to stop.